
DPIA Clinical Trials: How the EDPB Harmonised Template Reshapes Sponsor Obligations
The EDPB's 2026 harmonised DPIA template changes how sponsors conduct data protection impact assessments in clinical trials. Learn what it means for your programme.

Vendor GDPR in Clinical Trials: What the IQVIA CNIL Ruling Changes for Sponsors and Healthtech Companies
On 26 May 2026 the CNIL fined IQVIA Operations France EUR 5 million for failures in its two authorised health data warehouses, LRX and EMR. The decision exposes weaknesses in CRO data protection practice that have direct consequences for every pharmaceutical sponsor relying on a CRO to process patient, prescription or trial data. This article unpacks the four areas of failure, explains why pseudonymisation no longer offers the cover many sponsors assume, and sets out a practical oversight checklist for sponsor data controllers.

EU AI Act for Healthcare: What Life Sciences Companies Need to Know before August 2026
EU AI Act 2026 healthcare enforcement requires immediate compliance to avoid penalties.
FAQs
Our frequently questions


